Your browser doesn't support javascript.
loading
Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response.
Chen, Jinjin; Ye, Zhongfeng; Huang, Changfeng; Qiu, Min; Song, Donghui; Li, Yamin; Xu, Qiaobing.
Afiliación
  • Chen J; Department of Biomedical Engineering, Tufts University, Medford, MA 02155.
  • Ye Z; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
  • Huang C; Department of Biomedical Engineering, Tufts University, Medford, MA 02155.
  • Qiu M; Department of Biomedical Engineering, Tufts University, Medford, MA 02155.
  • Song D; Department of Biomedical Engineering, Tufts University, Medford, MA 02155.
  • Li Y; Department of Biomedical Engineering, Tufts University, Medford, MA 02155.
  • Xu Q; Department of Biomedical Engineering, Tufts University, Medford, MA 02155.
Proc Natl Acad Sci U S A ; 119(34): e2207841119, 2022 08 23.
Article en En | MEDLINE | ID: mdl-35969778

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Nanopartículas / Vacunas de ARNm / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Nanopartículas / Vacunas de ARNm / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2022 Tipo del documento: Article